RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
暂无分享,去创建一个
Z. Szallasi | A. Kibel | K. Mouw | L. Jia | L. Zou | H. Azuma | Z. Sztupinszki | C. Miao | T. Tsujino | Tomoaki Takai | T. Tsutsumi | Zengjun Wang | Fu Gui | L. Zou